Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Letter to the Editor

낮은 역가 MOG항체 양성 소견의 신중한 해석과 감별 진단의 중요성: 현재원, 김호진; J Mult Scler Neuroimmunol. 2025;16(1):33-34. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.33-34; Full text PubReader ePub PDF

Case Report

GM1, GD1a 항체 양성인 횡단성척수염과 병발한 급성운동축삭신경병의 임상적 증상과 예후: 김아영, 유홍근, 전종현, 권혁성; J Mult Scler Neuroimmunol. 2025;16(1):26-32. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.26-32; Full text PubReader ePub PDF

Original Article

Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France: Grégoire Mercier, David Pau, Guillaume Bourel, Manon Belhassen, Floriane Deygas, Clarisse Marchal, Sophie Larrieu, Alexandre Civet, Xavier Moisset; J Mult Scler Neuroimmunol. 2025;16(1):19-25. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.19-25; Full text PubReader ePub PDF Supplementary Material

Review Article

희귀 신경계질환 극복을 위한 전문가 단체와 환자 단체와의 협력: 김기훈, 권영남, 김준순, 김수영, 김승우, 박기홍, 박진성, 봉정빈, 석진명, 석흥열, 이혜림, 조은빈, 전병준, 오성일, 대한신경면역학회 홍보위원회; J Mult Scler Neuroimmunol. 2025;16(1):8-18. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.8-18; Full text PubReader ePub PDF

Review Article

신경학적 면역관문억제제 연관 부작용의 진단과 치료: 현재원; J Mult Scler Neuroimmunol. 2025;16(1):1-7. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.1-7; Full text PubReader ePub PDF

Neuroimage

미만성 경수막염으로 발현한 항-MOG 항체 연관질환: 김준순; J Mult Scler Neuroimmunol. 2024;15(2):85-86. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.85-86
Cited By 1; Full text PubReader ePub PDF

Case Report

단독 뇌간 및 척수 침범을 보인 MOG 항체 관련 질환 증례: 김예린, 채주희, 오선영; J Mult Scler Neuroimmunol. 2024;15(2):81-84. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.81-84; Full text PubReader ePub PDF

Original Article

흉선종 재발과 중증근무력증 악화 사이의 시간적 연관성: 오병철, 신하영, 양영호, 김승우; J Mult Scler Neuroimmunol. 2024;15(2):72-80. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.72-80; Full text PubReader ePub PDF Supplementary Material

Original Article

난치중증근무력증 환자의 치료에 대한 권고합의안: 이형수, 정혜윤, 김승우, 손은희, 남태승, 신경진, 강사윤, 김현진, 박진성, 윤별아, 석흥열, 봉정빈, 정연경, 홍윤호, 신하영; J Mult Scler Neuroimmunol. 2024;15(2):59-71. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.59-71; Full text PubReader ePub PDF

Review Article

클라드리빈에대한종설(개발부터임상그리고실제치료에이르기까지): 신경진; J Mult Scler Neuroimmunol. 2024;15(2):55-58. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.55-58; Full text PubReader ePub PDF

Review Article

다발성경화증 환자들에서 Ocrelizumab의 임상적 유용성에 대한 고찰: 안석원; J Mult Scler Neuroimmunol. 2024;15(2):49-54. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.49-54; Full text PubReader ePub PDF

Review Article

시신경척수염범주질환에서 Eculizumab의 치료적 역할: 김지은, 안석원; J Mult Scler Neuroimmunol. 2024;15(2):43-48. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.43-48; Full text PubReader ePub PDF

Neuroimage

대뇌 실질을 침범한 IgG4연관비후경수막염: 김기훈, 김수현, 현재원, 김호진; J Mult Scler Neuroimmunol. 2024;15(1):40-41. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.40; Full text PubReader ePub PDF

Case Report

시신경척수염 범주질환 환자의 감정실금 증례 1: 안석원; J Mult Scler Neuroimmunol. 2024;15(1):35-39. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.35; Full text PubReader ePub PDF

Case Report

다발경화증 환자에서 리툭시맙 치료 중 발생한 호중구 감소증: 김기훈, 김수현, 현재원, 김호진; J Mult Scler Neuroimmunol. 2024;15(1):31-34. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.31; Full text PubReader ePub PDF

Volume 16, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

7,611	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
4,160	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
3,745	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
3,614	Rituximab Treatment for Neuroimmunologic Disorders
2,963	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review

Cited By 4	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
Cited By 1	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	A Case of Post-Infective Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2025 by Korean Society of Neuroimmunology.